Literature DB >> 28246183

Bioassays and Inactivation of Prions.

Kurt Giles1,2, Amanda L Woerman1,2, David B Berry1, Stanley B Prusiner1,2,3.   

Abstract

The experimental study of prions requires a model for their propagation. However, because prions lack nucleic acids, the simple techniques used to replicate bacteria and viruses are not applicable. For much of the history of prion research, time-consuming bioassays in animals were the only option for measuring infectivity. Although cell models and other in vitro tools for the propagation of prions have been developed, they all suffer limitations, and animal bioassays remain the gold standard for measuring infectivity. A wealth of recent data argues that both β-amyloid (Aβ) and tau proteins form prions that cause Alzheimer's disease, and α-synuclein forms prions that cause multiple system atrophy and Parkinson's disease. Cell and animal models that recapitulate some of the key features of cell-to-cell spreading and distinct strains of prions can now be measured.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28246183      PMCID: PMC5538415          DOI: 10.1101/cshperspect.a023499

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  110 in total

1.  Cultured cell sublines highly susceptible to prion infection.

Authors:  P J Bosque; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 2.  Inactivation of prions by physical and chemical means.

Authors:  D M Taylor
Journal:  J Hosp Infect       Date:  1999-12       Impact factor: 3.926

3.  Resistance of scrapie agent to decontamination.

Authors:  A G Dickinson; D M Taylor
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

4.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Branched polyamines cure prion-infected neuroblastoma cells.

Authors:  S Supattapone; H Wille; L Uyechi; J Safar; P Tremblay; F C Szoka; F E Cohen; S B Prusiner; M R Scott
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.

Authors:  A Probst; J Götz; K H Wiederhold; M Tolnay; C Mistl; A L Jaton; M Hong; T Ishihara; V M Lee; J Q Trojanowski; R Jakes; R A Crowther; M G Spillantini; K Bürki; M Goedert
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

7.  Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

Authors:  M D Kane; W J Lipinski; M J Callahan; F Bian; R A Durham; R D Schwarz; A E Roher; L C Walker
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

8.  Elimination of prions by branched polyamines and implications for therapeutics.

Authors:  S Supattapone; H O Nguyen; F E Cohen; S B Prusiner; M R Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

9.  Infectivity of scrapie prions bound to a stainless steel surface.

Authors:  E Zobeley; E Flechsig; A Cozzio; M Enari; C Weissmann
Journal:  Mol Med       Date:  1999-04       Impact factor: 6.354

10.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

View more
  13 in total

1.  Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids.

Authors:  Mansoore Esmaili; Brian P Tancowny; Xiongyao Wang; Audric Moses; Leonardo M Cortez; Valerie L Sim; Holger Wille; Michael Overduin
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

2.  MSA prions exhibit remarkable stability and resistance to inactivation.

Authors:  Amanda L Woerman; Sabeen A Kazmi; Smita Patel; Yevgeniy Freyman; Abby Oehler; Atsushi Aoyagi; Daniel A Mordes; Glenda M Halliday; Lefkos T Middleton; Steve M Gentleman; Steven H Olson; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2017-08-28       Impact factor: 17.088

3.  Prion potentiation after life-long dormancy in mice devoid of PrP.

Authors:  Davy Martin; Fabienne Reine; Laetitia Herzog; Angélique Igel-Egalon; Naima Aron; Christel Michel; Mohammed Moudjou; Guillaume Fichet; Isabelle Quadrio; Armand Perret-Liaudet; Olivier Andréoletti; Human Rezaei; Vincent Béringue
Journal:  Brain Commun       Date:  2021-04-28

4.  Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.

Authors:  Airi Tarutani; Tetsuaki Arai; Shigeo Murayama; Shin-Ichi Hisanaga; Masato Hasegawa
Journal:  Acta Neuropathol Commun       Date:  2018-04-18       Impact factor: 7.801

5.  Use of different RT-QuIC substrates for detecting CWD prions in the brain of Norwegian cervids.

Authors:  Edoardo Bistaffa; Tram Thu Vuong; Federico Angelo Cazzaniga; Linh Tran; Giulia Salzano; Giuseppe Legname; Giorgio Giaccone; Sylvie L Benestad; Fabio Moda
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

6.  A role for astroglia in prion diseases.

Authors:  Adriano Aguzzi; Yingjun Liu
Journal:  J Exp Med       Date:  2017-11-21       Impact factor: 14.307

7.  Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions.

Authors:  Sarah Voth; Meredith Gwin; Christopher Michael Francis; Ron Balczon; Dara W Frank; Jean-Francois Pittet; Brant M Wagener; Stephen A Moser; Mikhail Alexeyev; Nicole Housley; Jonathon P Audia; Scott Piechocki; Kayla Madera; Autumn Simmons; Michaela Crawford; Troy Stevens
Journal:  FASEB J       Date:  2020-05-15       Impact factor: 5.191

8.  A Novel, Reliable and Highly Versatile Method to Evaluate Different Prion Decontamination Procedures.

Authors:  Hasier Eraña; Miguel Ángel Pérez-Castro; Sandra García-Martínez; Jorge M Charco; Rafael López-Moreno; Carlos M Díaz-Dominguez; Tomás Barrio; Ezequiel González-Miranda; Joaquín Castilla
Journal:  Front Bioeng Biotechnol       Date:  2020-10-29

Review 9.  Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.

Authors:  Z Jaunmuktane; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2020-02-11       Impact factor: 8.090

10.  Large-scale prion protein genotyping in Canadian caribou populations and potential impact on chronic wasting disease susceptibility.

Authors:  Maria Immaculata Arifin; Antanas Staskevicius; Su Yeon Shim; Yuan-Hung Huang; Heather Fenton; Philip D McLoughlin; Gordon Mitchell; Catherine I Cullingham; Sabine Gilch
Journal:  Mol Ecol       Date:  2020-09-10       Impact factor: 6.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.